Sartorius Stedim Biotech (MEX:DIM N) Cyclically Adjusted FCF per Share: MXN76.84 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:DIM N Sartorius Stedim Biotech SA MEX:DIM N
90 GF Score
Price MXN4,374.26
GF Value MXN5,277.61
! 5 Warning Signs
View Full Analysis

What is Sartorius Stedim Biotech Cyclically Adjusted FCF per Share?

Sartorius Stedim Biotech MEX:DIM N 90 Cyclically Adjusted FCF per Share is MXN76.84 as of Jun. 2026. GuruFocus rates MEX:DIM N with a GF Score™ of 90/100 and a GF Value™ of MXN5,277.61. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Sartorius Stedim Biotech's adjusted free cash flow per share for the three months ended in Jun. 2026 was MXN15.519. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN76.84 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Sartorius Stedim Biotech's average Cyclically Adjusted FCF Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Sartorius Stedim Biotech was 7.50% per year. The lowest was 7.50% per year. And the median was 7.50% per year.

As of today (2026-07-25), Sartorius Stedim Biotech's current stock price is MXN4374.26. Sartorius Stedim Biotech's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was MXN76.84. Sartorius Stedim Biotech's Cyclically Adjusted Price-to-FCF of today is 56.93.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Sartorius Stedim Biotech was 161.90. The lowest was 48.87. And the median was 72.08.


Sartorius Stedim Biotech  (MEX:DIM N) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Sartorius Stedim Biotech's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=4374.26/76.84
=56.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Sartorius Stedim Biotech was 161.90. The lowest was 48.87. And the median was 72.08.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Sartorius Stedim Biotech Cyclically Adjusted FCF per Share Related Terms


Sartorius Stedim Biotech Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Sartorius Stedim Biotech's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius Stedim Biotech Cyclically Adjusted FCF per Share Chart

Sartorius Stedim Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 61.86 64.06 70.24 64.16

Sartorius Stedim Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.71 76.53 64.16 83.96 76.84

MEX:DIM N vs ISRG, BDX, MDLN: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius Stedim Biotech Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sartorius Stedim Biotech's Cyclically Adjusted Price-to-FCF falls into.


MEX:DIM N
90GF Score
Sartorius Stedim Biotech SA MEX:DIM N
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sartorius Stedim Biotech Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sartorius Stedim Biotech's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=15.519/131.3638*131.3638
=15.519

Current CPI (Jun. 2026) = 131.3638.

Sartorius Stedim Biotech Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201512 0.000 99.717 0.000
201606 0.000 100.717 0.000
201612 0.000 101.217 0.000
201706 0.000 102.117 0.000
201709 0.000 102.717 0.000
201712 0.000 102.617 0.000
201803 2.627 102.917 3.353
201806 0.891 104.017 1.125
201809 4.652 104.718 5.836
201812 4.084 104.217 5.148
201903 11.535 104.217 14.540
201906 6.518 105.718 8.099
201909 11.544 106.018 14.304
201912 11.016 105.818 13.675
202003 25.088 105.718 31.174
202006 15.671 106.618 19.308
202009 29.622 105.818 36.773
202012 1.999 105.518 2.489
202103 37.357 107.518 45.642
202106 29.304 108.486 35.484
202109 25.101 109.435 30.131
202112 6.866 110.384 8.171
202203 22.471 113.968 25.901
202206 -5.698 115.760 -6.466
202209 8.419 118.818 9.308
202212 16.352 119.345 17.999
202303 10.467 122.402 11.233
202306 0.060 123.140 0.064
202309 -2.119 124.195 -2.241
202312 46.998 123.773 49.880
202403 -9.981 125.038 -10.486
202406 28.192 125.882 29.420
202409 41.913 126.198 43.629
202412 46.044 127.041 47.611
202503 12.392 127.779 12.740
202506 10.719 128.412 10.965
202509 14.631 129.255 14.870
202512 28.179 129.361 28.615
202603 26.637 131.258 26.658
202606 15.519 131.364 15.519

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN76.84 mean?
Sartorius Stedim Biotech (MEX:DIM N) has a Cyclically Adjusted FCF per Share of MXN76.84 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Sartorius Stedim Biotech and its competitors.
Is Sartorius Stedim Biotech's Cyclically Adjusted FCF per Share too high?
Sartorius Stedim Biotech's current Cyclically Adjusted FCF per Share is MXN76.84. Overall, Sartorius Stedim Biotech has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Sartorius Stedim Biotech's Cyclically Adjusted FCF per Share compare to ISRG and BDX?
Sartorius Stedim Biotech's Cyclically Adjusted FCF per Share of MXN76.84 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Sartorius Stedim Biotech and its competitors. Sartorius Stedim Biotech's current Cyclically Adjusted FCF per Share is MXN76.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius Stedim Biotech stock overvalued right now?
Sartorius Stedim Biotech (MEX:DIM N) has a current Cyclically Adjusted FCF per Share of MXN76.84. The stock's GF Value™ is MXN5,277.61, compared to a current price of MXN4,374.26 — trading 17.1% below its estimated fair value. The current Cyclically Adjusted FCF per Share is MXN76.84. Sartorius Stedim Biotech's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Sartorius Stedim Biotech (MEX:DIM N), the current Cyclically Adjusted FCF per Share is MXN76.84 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sartorius Stedim Biotech (MEX:DIM N) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius Stedim Biotech stock appears to be undervalued. The current stock price of MXN4,374.26 is trading 17.1% below its estimated GF Value™ of MXN5,277.61.

Key valuation signals for MEX:DIM N:

  • Cyclically Adjusted FCF per Share: MXN76.84
  • GF Value™: MXN5,277.61 vs. price of MXN4,374.26 (17.1% below fair value)
  • GF Score™: 90/100 with 5 warning signs

No single metric tells the full story. See the MEX:DIM N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sartorius Stedim Biotech Business Description

Address Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. It sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.
90GF Score

Get the complete analysis for MEX:DIM N

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN4,374.26
Price
MXN5,277.61
GF Value